发明名称 A METHOD FOR SELECTING RESPONDERS TO BLOCKADE OF INTEGRIN RECEPTORS
摘要 Provided is a method for identifying a subject belonging to a group responding to a blockade of alpha2beta1 integrin receptors as determined by a decrease in platelet aggregation, comprising a) determining a single nucleotide polymorphism (SNP) C/T located at base pair 807 of alpha2 integrin cDNA, in a sample obtained from said subject, b) measuring the expression level of alpha2beta1 integrin on platelets obtained from a subject having a CT807 genotype, and c) identifying as a subject responding to the blockade of alpha2beta1 integrin receptors , a subject having either a TT807 genotype, or having a CT807 genotype combined with a high expression level of alpha2beta1 integrin, wherein high expression level of aplha2beta1 integrin means a statistically significant increase in said expression level as compared to the expression level of alpha2beta1 integrin in subjects having a CC807 genotype.
申请公布号 NZ580235(A) 申请公布日期 2011.03.31
申请号 NZ20080580235 申请日期 2008.04.16
申请人 BIOTIE THERAPIES CORPORATION 发明人 MARJAMAKI, ANNE;NISSINEN, LIISA
分类号 C12Q1/68 主分类号 C12Q1/68
代理机构 代理人
主权项
地址